Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Annexon Analyst Ratings
Annexon Biosciences: Buy Rating Backed by Promising Data Releases and Strategic Long-term Potential
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
TD Cowen Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)
Wells Fargo Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $14
Buy Rating Affirmed for Annexon Biosciences Amidst Promising Clinical Developments and Market Potential
Annexon Analyst Ratings
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Annexon Analyst Ratings
Buy Rating Justified: Undervalued Annexon Biosciences Poised for Growth With Positive Clinical Trials and Strong Cash Position
Annexon Biosciences: Accelerated Timelines and Financial Stability Bolster Buy Rating